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Available online 13 November 2018Purpose: Dynamic CEST studies such as dynamic glucose enhanced imaging, have gained a lot of attention
recently. The expected CEST effects after injection are rather small in tissue especially at clinical field
strengths (0.5–2%). Small movements during the dynamic CEST measurement together with a
subtraction-based evaluation can lead to pseudo CEST effects of the same order of magnitude. These arti-
facts are studied herein.
Methods: A brain tumor patient 3D-CEST baseline scan without glucose injection performed at 3 T is used
to generate a virtual dynamic measurement introducing different kinds of simulated motion and B0 shifts.
Results: Minor motion (0.6 mm translations) and B0 artifacts (7 Hz shift) can lead to pseudo effects in the
order of 1% in dynamic CEST imaging. Especially around tissue interfaces such as CSF borders or tumor
affected areas, the pseudo effect patterns are non-intuitive and can be mistaken as dynamic agent uptake.
Conclusion: Correction or mitigation for small motions is crucial for dynamic CEST imaging, especially in
subjects with lesions. Concomitant B0 alterations can as well induce pseudo CEST effects at 3 T.
 2018 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Since it was first demonstrated by Wolff and Balaban in 1990
[1], chemical exchange saturation transfer (CEST) has emerged as
an alternative MRI contrast [2–5]. Among numerous key biomole-
cules which can be indirectly detected via their chemical exchange
with water, D-glucose or its analogues in particular has recently
shown potential as a new contrast agent with CEST [6,7], chemical
exchange sensitive spin lock (CESL) [8–11] or chemical exchange
based T2 relaxation enhancement [12]. Dynamic CEST and CESL
of glucose (glucoCEST/glucoCESL) have been performed to study
tumor models in animals [6,13] and patients with glioblastoma
[10,14] as it monitors the uptake and wash-out of glucose. Gluco-
CEST spectra are obtained pre- and post-intravenous injection of
exogenous glucose, and the difference between these spectra, so
called glucose contrast enhancement (GCE) [6] or dynamic glucoseenhanced (DGE) contrast [7,9,13,14] is assumed to mostly reflect
the CEST effect of the glucose injection.
The DGE signal is relatively small, with values less than 5% in
tumor areas at both 3 T and 7 T, and therefore vulnerable to sub-
ject’s motion [10]. Even 1–2% of artifactual signal due to motion
can hamper the sensitivity of intrinsic signal changes as it has been
widely reported in other modalities including functional brain MRI
(fMRI). For instance, blood oxygenation level dependent (BOLD)
effects of interest are only a few percent in magnitude and there-
fore image time series fluctuation levels must be much lower than
these small signal changes to accurately measure them. As motion
correction and co-registration are mandatory steps in fMRI post-
processing, similar attempts have been recently made in gluco-
CEST/glucoCESL studies, which observed erroneous signal due to
severe patient’s movement [10,14]. Alternatively, use of immobi-
lization devices was reported to reduce patient’s motion [15], but
this option may not be globally available due to a patient’s discom-
fort level and may conflict with local ethics.
In the absence of motion constraints, it is essential to investi-
gate the influence of motion in glucoCEST. To this end, we aimed
to establish a systematic investigation of data post-processing in
this study.
Fig. 1. (a) B0 corrected Z-spectra in different ROIs of two neighboring slices. (b) Z-value at 1.8 ppm used as the base 3D image in the following virtual dynamic scan. (c) T1
contrast enhanced image of this slice depicting the tumor localization.
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2.1. 3 T CEST MR imaging
3 T CEST imaging was performed on a whole body MRI system
(PRISMA, Siemens Healthcare, Erlangen, Germany) on 1 healthy
subject and one newly diagnosed brain tumor patient following
an informed, written consent as approved by the local Ethics Com-
mittee of Tübingen and in agreement with all local regulations. A
3D snapshot-CEST acquisition [16] optimized for 3 T [17] consisted
of a pre-saturation module of 5 s followed by a readout module of
duration TRO = 3.5 s, in which a train of RF and gradient spoiled gra-
dient echoes with centric spiral reordering was acquired. Imaging
parameters were FOV = 220  180  48 mm3, resolution
1.7  1.7  3 mm3, matrix size 128, 80% FOV in the first phase-
encoding direction, phase encoding acceleration factor 2 and ellip-
tical scanning; TE = 2 ms, TR = 5 ms, BW = 400 Hz/pixel, 18 slices,
FA = 6 and elongation factor E = 0.5 (rectangular spiral reordered).
The CEST saturation period consists of 1 Gaussian-shaped RF pulse,
using a pulse duration of tpulse = 100 ms, and mean B1 = 3 mT,
adapted from 9.4 T settings [18,19]. After the pulse, a crusher gra-
dient was applied to spoil residual transversal magnetization. A
separate WASABI measurement was acquired for B0 and B1 map-
ping [20].
In the patient, Z-spectrum data was obtained after saturation at
36 offsets in the range of ±3 ppm and normalized by M0 scans with
12 s of relaxation and saturation at 300 ppm.
In the healthy subject, a scan was acquired with only 3 offsets,
at 0.9, 1.2 and 1.5 ppm with 35 repetitions (20 min measurements
total). The subject was instructed to lay still. From this dataset,
only the dynamic motion from the SPM registration algorithm
and the relative B0 difference to the first image were used. The rel-
ative B0 difference was calculated from the GRE phase images as
described by Windschuh et al. [21].
2.2. Data evaluation
Z-spectrum data was corrected for motion using SPM [22], fol-
lowed by B0 inhomogeneity correction using the WASABI approach[20]. CEST images were generated from the Z-value, Z(Dx), given
by the ratio of the saturated image Ssat(Dx) and the fully relaxed
image S0
ZðDxÞ ¼ SsatðDxÞ
S0
ð1Þ2.3. Motion and B0 shift simulation
To simulate the effect of known translations and rotations,
single-axis rigid body transformations employing linear interpola-
tion were applied using custom written MATLAB code (The Math-
works, Natick, Massachusetts, USA) on a 3D stack acquired at a
single frequency offset. Subsequently, the difference maps
between pre-transformation and post-transformation were gener-
ated to simulate DGE contrast in the presence of motion according
to the following relation
Zdiff ¼ Zpre  Zpost: ð2Þ
For B0 shift simulation, small B0 shifts were introduced in the
Zpost data. The combined effect of motion and B0 shifts was also
investigated, with the B0 shift introduced after the transformations
were applied to all Z-spectrum data.
To study the effect of realistic motion, a motion pattern was
obtained by SPM registration of dynamic subject data. The motion
pattern and the concomitant inhomogenous B0 alterations were
applied as a series of rigid body transformations to the patient data
stack to generate a dynamic measurement with controlled motion,
and simulated DGE images were computed according to Eq. (2).
The inverse motion transformation was then applied to simulate
motion correction, and the dynamic contrast was recalculated for
comparison.
3. Results & discussion
Fig. 1 shows Z-spectra in various tissue ROIs (grey matter,
white matter, CSF and tumor) of B0 corrected data, and from
the same ROI evaluation but of a neighboring slice. Depending
on different ROI positions as well as the frequency offset, the
Fig. 2. Slice 11: Difference images after virtual rigid body translations (row 1–3), rotations (row 4–6) and B0 shifts (bottom row) applied to the 3D baseline image as shown
for one slice in Fig. 1. Abbreviations: RL left-right, AP anterior-posterior, HF head-foot.
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differences in the Z-spectra up to several percent. To simulate
a relatively robust glucoCEST experiment, the 3D image given
by the Z-value of the frequency offset 1.8 ppm is used, where
the tissue difference as well the B0 dependency is smaller thanat 1 ppm. Z (1.8 ppm) is shown in Fig. 1b and shows an
endogenous CEST/MT contrast in the tumor area, as identified
in the T1-contrast enhanced image in Fig. 1c.
In Fig. 2 the virtual difference images Zdiff (Eq. (2)) after the rigid
body transformations (applied on the CEST data of Fig. 1b) are
Table 1
Tumor ROI averaged values of all sub figures of Fig. 2 in same order of columns and rows. The tumor ROI was defined in the T1ce image (Fig. 1) by the ring enhancement.
Zdiff 0.3 mm 0.6 mm 0.3 mm 0.6 mm
LR-RL 0.03% 0.07% 0.01% 0.00%
PA-AP 0.19% 0.38% 0.20% 0.40%
FH-HF 0.30% 0.56% 0.33% 0.72%
rot HF 0.27% 0.56% 0.28% 0.59%
angle 0.5 1 0.5 1
rot. AP 0.52% 1.14% 0.41% 0.75%
rot. RL 0.34% 0.63% 0.41% 0.89%
+10 Hz +20 Hz 10 Hz 20 Hz
dB0 1.65% 3.29% 1.81% 3.63%
Fig. 3. Small motion worst case scenarios for difference images of a dynamic CEST contrast (a, b) showing signal in the tumor region similar to the gadolinium contrast-
enhancement (c, g). The inverse transformations are depicted in (d, e) for completeness. (f) Shows ROI analysis of ROIs defined in (c) for the contrast in (a) exemplarily; up to
2% effect can be generated in worst case. (g) and (h) shows the same as (b) and (c), respectively, but for the whole 3D image with b and c included; in other slices than (b)
hypointensities in the tumor region can be observed as well.
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Fig. 4. Co-registration information of actual movement which occurred in a healthy subject scan (see Fig. 5a,b) and corresponding B0 alterations were transferred to the
virtual dynamic patient measurement for the full movement. The virtual dynamic contrast scan was created as difference to the original 3D volume (a). In the tumor area,
artifacts can be seen in the range of 1% even with very small motion (scan 1–19 in a) and further increase to several percent for larger motion (scan 20–34 in a). After
retrospective motion correction of this stack, visible in (b), residual artifacts are still observed, especially at tissue boundaries. For more detailed ROI evaluation see Fig. 5.
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and B0 shifts only (row 7). Typical motion artifacts visible as
bright-dark patterns are observed in healthy tissue. Hyperintensi-
ties at ventricle edges are visible in the case of anterior-poster (AP)
and right-left (RL) shifts, and signals in the sulci resembling vessels
in the case of head-foot (HF) rotation. Certain motion (rotate RL,
rotate AP, HF shift) can lead to untypical artifacts with hyperinten-
sities only in the tumor area. Constant B0 shift can be identified by
strong signal changes in WM. Negative B0 shifts can lead again to
tumor hypointensities as compared to surrounding tissue. ROI
averaged values of a tumor ROI for the same transformations can
be found in Table 1.
In Fig. 3, a worst-case scenario for difference of images of
Fig. 1b before and after transformations was created by applying
combinations of different translations, rotations, (Fig. 3a) and B0
shifts (Fig. 3b) to create a hyperintensity in the tumoral area
(see Fig. 3c) and low signals everywhere else. This depicts the
non-intuitive motion artifacts of dynamic CEST scans in tumoral
areas, and that they can be easily mistaken as an uptake signal
which nicely matches the necrotic or ring-enhancement region
of the tumor. ROI analysis reveals that up to 2% pseudo CEST
effect can be generated in such a worst case only by motion
(Fig. 3f). The effect of the inverse transformation is shown in
Fig. 3d and e for comparison. Fig. 3g shows the worst case of
Fig. 3b again but for all slices of the 3D volume, together with
all slices of the T1-contrast enhanced images Fig. 3h. In this
view, the same motion artifact (dark and bright pattern) below
and above the tumor is visible. This further emphasizes that sin-
gle slice evaluation is prone to non-intuitive and not identifiable
motion artifacts.
In the last step, a measured dynamic movement transformation
and the concomitant B0 alterations were applied to the same tumor
data to get an idea of a realistic motion artifact (Fig. 4). Similar pat-
terns as illustrated in Fig. 2 are observed: for relatively small
motion, pseudo-CEST effects in the range of 1% can be still
observed. To test the effectiveness of an ideal motion correction,the reverse transformation was applied to the same data
(Fig. 4b). This did not result in a perfect image of zeros, but instead
some residual artifacts are visible especially at tissue and tumor
edges. This is mainly due to the interpolation during the transfor-
mation. We could of course perform the back-transformation with-
out any interpolation, however this case is more realistic as in any
motion correction of real data, an interpolation also has to be per-
formed. This means that motion artifacts can in principal be sup-
pressed to a great amount, but might still arise at tissue
boundaries. In Fig. 5 the used motion data and ROI evaluations of
the data in Fig. 4 are shown for the Zdiff contrast with and without
motion correction, and with and without B0 correction. This analy-
sis reveals that motion is the dominant influence, yet, motion
induced B0 changes can still alter the effect strength by about
0.5% at 3 T, thus a combined motion and B0 correction is expected
to yield the best results. Going to higher field strengths than 3 T
will make B0 issues and their dynamic correction even more
important.
In summary, the results indicate that motion correction is nec-
essary even for small motions and its effectiveness must be verified
to draw correct conclusions for any observed CEST effects below
2%. CEST effects belowmotion artifacts size are not reliable. Motion
of DGE CEST imaging was already pointed out as a contributor to
observed signal changes in the literature [10,14]. With the given
analysis herein it is easier to identify certain changes as induced
by motion, e.g. changes in grey matter can easily be due to rota-
tions along the HF axis (see Fig. 2), and observed highlights at
the edge of the ventricles might be an indicator for residual motion
in RL or AP direction. As long as these pseudo CEST effects are pre-
sent, interpretation of hyperintensities within regions of lesions
have to be done carefully, and motion data should be compared
with uptake curves. We recommend to carefully analyze the tem-
poral signal-to-noise ratio (tSNR) employing repeated scans with-
out glucose injection, as well as analysis of dynamic B0 mapping,
before moving to protocols with injection in healthy subjects and
patients.
Fig. 5. Co-registration information of actual movement which occurred in a healthy
subject scan (a, b) and corresponding B0 changes (c). (d–f) ROI evaluations of data
shown in Fig. 4 in ROIs as defined in T1ce inlay in (d). (d) DGE contrast as a function
of the measurement index without motion correction and without B0 correction, (e)
DGE contrast with motion correction but without B0 correction, and (f) DGE
contrast with both motion and B0 correction. While motion is the dominant
influence, motion induced B0 changes can still alter the effect strength by about
0.5% (compare e, and f).
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As dynamic CEST is extremely sensitive to motion artifacts,
motion correction or mitigation is very important to not misinter-
pret false-positive signals as CEST agent uptake. Motion artifacts
which can be identified in 3D acquisitions show some typical
bright-dark patterns, but may show very non-intuitive hyperinten-
sities depending on the slice and lesion geometry. When motion is
effectively corrected, a more robust and sensitive dynamic CEST
contrast will be achieved. However, even small residual motion
artifacts can give rise to discernable signals which can resemble
uptake of contrast agents. Attempting dynamic CEST measure-
ments in patients without putting an effort into sophisticated
motion correction is strongly ill-advised. Thus, we encourage MRI
researchers to develop novel motion mitigation and correctionapproaches to improve robustness and reliability of dynamic and
conventional CEST approaches at all field strengths.Acknowledgments
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